Drug Profile
Research programme: estrogen topical - CervoMed
Alternative Names: Biodegrabable estrogen HYG-102 - Hygeia; estrogen topical - Hygeia; HYG 101; HYG-102; RES-102Latest Information Update: 17 Aug 2023
Price :
$50
*
At a glance
- Originator Yale University
- Developer Hygeia Therapeutics
- Class Hormones
- Mechanism of Action Estrogen receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Atrophic vaginitis; Skin aging
Most Recent Events
- 16 Aug 2023 EIP Pharma has merged with Diffusion Pharmaceuticals to form CervoMed
- 16 Jul 2016 No recent reports of development identified for preclinical development in Atrophic-vaginitis in USA (Topical)
- 16 Jul 2016 No recent reports of development identified for preclinical development in Skin-aging in USA (Topical)